Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NON DESTINÉ À LA DISTRIBUTION AUX SERVICES DE FIL DE PRESSE DES ÉTATS-UNIS NI À LA DIFFUSION AUX ÉTATS-UNIS MONTRÉAL, 04 juin 2026 (GLOBE NEWSWIRE) -- PyroGenèse inc. (« PyroGenèse » ou la «...
-
ALLENTOWN, Pa., June 04, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine employees raised $2,500 during the organization’s 2026 Medical Laboratory Professionals Week celebration, with proceeds benefiting...
-
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant...
-
Participants retained ~78% of GLP-1 induced total body weight loss one year after discontinuation and a single Revita procedure 5.3% mean weight change observed with Revita (n=15); published...
-
TORONTO, June 04, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today announced the award of a structural, mechanical and...
-
SD Government, a Gogo company, has secured a significant multi-year contract with the U.S. National Oceanic and Atmospheric Administration (NOAA).
-
FDA grants orphan drug status to Attralus AT-02 for AL amyloidosis, a novel therapy targeting toxic amyloid removal
-
BEDFORD, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today...
-
Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give...
-
Orion Reports FY 2026 Revenue of $86M and Adjusted EBITDA of $2.2M After Continued Growth in Q4